SEFAM

What SEFAM does

SEFAM is a French privately-held medical device company, founded in 1984 and headquartered in Neuilly-sur-Seine with manufacturing operations in Villers-lès-Nancy, France. The company designs, manufactures, and commercializes devices for the diagnosis and treatment of sleep-disordered breathing, principally obstructive sleep apnea syndrome (SAOS). Its portfolio is organized around two pillars: treatment devices, led by the Néa CPAP/AutoPAP (the first foam-free CPAP on the market, built on patented Néalveole® technology), the S.Box family (originally designed with Philippe Starck, launched 2014), and the EcoStar line; and diagnostic devices, including the compact SOMNOtouch polygraph and the full-featured SOMNO HD polysomnograph, distributed under partnership with SOMNOmedics.

The product stack is supported by a three-tier software ecosystem: Sefam Analyze (clinician data analysis), Sefam Connect (web-based remote patient monitoring and device fleet administration), and Sefam Access (patient mobile app for daily therapy follow-up and data sharing), with the PolyLink accessory enabling control polygraphy under treatment. All products carry CE marking under EU Medical Device Directive MDD 93/42/CEE Annex II.3. SEFAM employs a sales-led go-to-market, reaching customers through a national network of nine regional sales representatives in France, home healthcare providers (prestataires de santé) that install and service CPAP equipment in patient homes, and international distribution partners serving over 60 countries. Revenue is generated primarily through hardware sales of treatment and diagnostic devices and accessories, with a smaller recurring software subscription layer via Sefam Connect, and pricing is quote-based rather than publicly disclosed.

Name

SEFAM

Legal name

SEFAM

Website

https://sefam-medical.com

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

51–100 employees

Short description

SEFAM is a French privately-held medical device company that designs, manufactures, and sells CPAP/AutoPAP treatment devices and sleep-diagnostic equipment, serving sleep apnea patients, clinicians, and home healthcare providers in France and 60+ countries.

Ownership category

akta.pro rank

Product category

Sleep Apnea Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV) (HLAHAGAA)

akta.pro secondary industries

Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy) (HLAHAGAB), Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD), Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF)

Keywords

• CPAP therapy devices
• Sleep apnea treatment
• Sleep diagnostic equipment
• Polysomnography systems
• Respiratory medical devices

Headquarters

HQ city

Villers-lès-nancy

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Medical Device Sales: Sale of CPAP and AutoPAP treatment devices (Néa, S.Box, EcoStar) and diagnostic equipment (SOMNOtouch, SOMNO HD) to healthcare providers and patients.
2. Accessories and Consumables: Sale of accessories including humidifiers, tubes, filters, SD cards, carrying cases, and PolyLink sensors for treatment devices.
3. Software Subscriptions: Remote patient monitoring and data management through Sefam Connect platform for healthcare providers managing patient fleets.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

SEFAM designs, manufactures, and sells medical devices for the diagnosis and treatment of sleep-disordered breathing. Its portfolio includes CPAP and AutoPAP treatment devices (Néa, S.Box, EcoStar), polygraphy and polysomnography diagnostic equipment (SOMNOtouch, SOMNO HD), and connected software platforms (Sefam Analyze, Sefam Connect, Sefam Access) for patient monitoring and treatment follow-up. Products are CE-marked under EU Medical Device Directive MDD 93/42/CEE and used in over 60 countries.

Product overview

SEFAM is a French medical device company that designs and manufactures sleep-disordered breathing diagnostic and treatment solutions. The product portfolio consists of two main pillars: (1) treatment devices — the Néa CPAP/AutoPAP (foam-free, incorporating proprietary Néalveole® technology), the S.Box by Starck family (S.Box, S.Box Duo, S.Box Duo ST, S.Box C), and Ecostar; and (2) diagnostic equipment — SOMNOtouch (compact polygraphe/polysomnograph) and SOMNO HD (full polysomnograph). These hardware devices are supported by a suite of software and applications: Sefam Analyze (professional data analysis), Sefam Connect (web platform for remote patient monitoring and device fleet management), Sefam Access (patient mobile app for treatment follow-up), and PolyLink (accessory enabling polygraphy under treatment). All products carry CE marking under EU Medical Device Directive MDD 93/42/CEE Annex II.3.

Differentiator

Problem solved

Functional benefit

Brands

• Néa: First foam-free CPAP (Continuous Positive Airway Pressure) device featuring proprietary Néalveole technology for treating sleep apnea.
• S.Box
• Ecoster
• SOMNOtouch
• SOMNO HD
• Néalveole
• PolyLink
• SEFAM Analyze
• SEFAM Connect
• SEFAM Access

Products and services

• Néa (Néa INFO, Néa AUTO) SEFAM's flagship CPAP and AutoPAP device, marketed as the first foam-free CPAP on the market. It incorporates the proprietary Néalveole® technology enabling silent operation without foam, with connectivity via Modem, Wi-Fi, and Bluetooth Low Energy (BLE). Features include event detection (obstructive and central apneas/hypopneas), Mask Select, Circuit Select, Mask Off, iRamp, Intelligent Start, and an optional heated humidifier with Adaptative ThermoControl. It is intended for patients diagnosed with obstructive sleep apnea syndrome (SAOS).
• S.Box by Starck (S.Box, S.Box Duo, S.Box Duo ST, S.Box C) CPAP device launched in 2014, designed by Philippe Starck, representing SEFAM's earlier treatment product line before Néa. Variants include S.Box Duo, S.Box Duo ST, and S.Box C, intended for patients with obstructive sleep apnea requiring CPAP therapy.
• EcoStar CPAP treatment device in SEFAM's product portfolio, with available patient brochures and user manuals. Targeted at patients requiring CPAP therapy for obstructive sleep apnea.
• SOMNOtouch Compact polygraph (polygraphe) that can evolve into a polysomnograph. Measuring 85x55x18mm and weighing 64 grams, it is one of the smallest devices of its kind in the world, practical to install, comfortable for patients, and suitable for pediatric use from 1 month of age. Targeted at sleep specialists and clinicians diagnosing sleep-disordered breathing.
• SOMNO HD Full-featured polysomnograph capable of performing all types of sleep examinations including diagnostic in sleep laboratory with video and continuous monitoring, TILE and TME. Its dual-hemisphere headpiece has 17 electrophysiological channels and a sampling frequency of 4,000 Hz, with configurations up to 70 channels. Designed for sleep laboratories and clinicians performing complete polysomnography.
• PolyLink Accessory for SEFAM CPAP devices that records all essential parameters for a control polygraph during treatment, with real-time synchronization of patient data. Includes wireless sensors for thoraco-abdominal movements, body position, and SpO2 saturation, and is compatible with Sefam Analyze for manual or automatic scoring. Targeted at clinicians performing polygraphy under treatment.
• Sefam Analyze Software application for healthcare professionals for the analysis of all treatment data recorded by SEFAM devices, including compliance, leaks, AHI, treatment pressure, and detailed flow and pressure curves. Data is summarized visually in night calendars and configurable detailed reports, with validation via HD curves. Targeted at sleep specialists and clinicians managing CPAP patients.
• Sefam Connect Web application compatible with all SEFAM connected treatment devices. It enables secure hosting and sharing of tele-transmitted health data, machine fleet administration, efficient patient follow-up in their therapeutic journey, and remote CPAP parameter configuration. Targeted at home healthcare providers and clinicians managing fleets of CPAP patients.
• Sefam Access (Sefam Access Lite, Sefam Access Pro) Mobile application for patients equipped with a SEFAM CPAP device, enabling daily follow-up of sleep quality (duration, leak levels, number of respiratory events), synchronization with other health data (weight, physical activity, blood pressure, heart rate), secure data transfer to healthcare professionals, and remote CPAP configuration via smartphone.

Quantifiable outcome

• Significant reduction or elimination of apneas and hypopneas from first night of use
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

One partnership is on record.

• SOMNOmedicscoreTechnology or IntegrationSEFAM distributes SOMNOtouch and SOMNO HD diagnostic devices (polysomnographs/polygraphs) for sleep disorder diagnosis. SOMNOtouch is a compact polygraph evolvable to polysomnograph, while SOMNO HD is a complete polysomnograph capable of full sleep lab examinations. SOMNOtouch RESP is a trademark of SOMNOmedics.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Fisher & Paykel Healthcare: New Zealand-listed respiratory care company with a leading CPAP mask franchise (Brevida, Simplus) and growing CPAP flow-generator offering. Comparable because it addresses the same OSA patient and HCP customer base with overlapping hardware categories.
• Natus Medical: Broad neurodiagnostics and sleep diagnostics platform with PSG systems and related consumables. Comparable to SEFAM's diagnostic side, competing in hospital sleep labs and serving overlapping neurology/sleep-specialist customers.

Emerging players

• Inspire Medical Systems: US-listed medical device company offering an implantable neurostimulation alternative to CPAP for OSA. Comparable because it competes for the same severe-OSA patient population, albeit with a fundamentally different treatment modality.
• SOMNOmedics: Germany-based specialist in polysomnography and home sleep testing (SOMNOtouch, SOMNO HD). Comparable because SEFAM distributes SOMNOmedics' diagnostic devices in France—the partnership makes them both a peer and a channel partner, with overlapping product categories.
• Itamar Medical (ZOLL Itamar): Sleep apnea diagnostics company built around the WatchPAT home sleep testing device. Comparable to SEFAM's diagnostic pillar and a credible competitor in the same physician-prescribed OSA screening workflow.

Direct peers

• BMC Medical: China-headquartered CPAP/APAP and respiratory device manufacturer with broad international distribution. Comparable to SEFAM as a mid-sized CPAP specialist pushing into global markets with cost-competitive offerings.
• Philips Respironics: Historically the second pillar of the global CPAP market (DreamStation family) and a direct competitor to SEFAM in hospital, homecare, and DME channels. The active foam-related recall has reshaped its competitive position but it remains the most direct product-category peer.
• Löwenstein Medical: Germany-based specialist in sleep and ventilation therapy, with CPAP/APAP/ASV devices, hospital ventilators, and polysomnography. A strong European-headquartered peer that competes head-to-head with SEFAM in DACH and EU homecare channels.
• ResMed: Global leader in CPAP/APAP devices, masks, and connected sleep-health software (myAir, AirView). Directly competes with SEFAM in CPAP hardware and increasingly in remote patient monitoring, with materially larger scale and a global salesforce.
• Apex Medical: Taiwan-based manufacturer of CPAP/APAP, BiPAP, and respiratory care products with global distribution. Comparable to SEFAM as a similarly-sized, sleep-and-respiratory-focused device company competing in international DME and homecare channels.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/SefamIndia
• LinkedInlinkedin.com/company/sefam-medical

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SEFAM